Cargando…
Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity
The asymptomatic phase of type 1 diabetes is recognised by the presence of beta cell autoantibodies in the absence of hyperglycaemia. We propose that an accurate description of this stage is provided by the name ‘Autoimmune Beta Cell Disorder’ (ABCD). Specifically, we suggest that this nomenclature...
Autores principales: | Bonifacio, Ezio, Mathieu, Chantal, Nepom, Gerald T., Ziegler, Anette-G., Anhalt, Henry, Haller, Michael J., Harrison, Leonard C., Hebrok, Matthias, Kushner, Jake A., Norris, Jill M., Peakman, Mark, Powers, Alvin C., Todd, John A., Atkinson, Mark A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516264/ https://www.ncbi.nlm.nih.gov/pubmed/27785529 http://dx.doi.org/10.1007/s00125-016-4144-8 |
Ejemplares similares
-
Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease
por: Ziegler, Anette-G., et al.
Publicado: (2016) -
Consumer responses to rebranding to address racism
por: Kalaitzandonakes, Maria, et al.
Publicado: (2023) -
Uncharted constellations: asterisms, single-source and rebrands
por: Barentine, John C
Publicado: (2016) -
Reclaiming or rebranding marketing: implications beyond digital
por: Ritter, Thomas
Publicado: (2020) -
Rebranding Nutritional Care for Critically Ill Patients
por: Elena Mirea, Liliana, et al.
Publicado: (2023)